| NDC Code | 50090-6180-0 |
|---|
| Package Description | 5 VIAL, SINGLE-DOSE in 1 CARTON (50090-6180-0) / .5 mL in 1 VIAL, SINGLE-DOSE (50090-6180-1) |
|---|
| Product NDC | 50090-6180 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Menquadfi |
|---|
| Non-Proprietary Name | Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20200423 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125701 |
|---|
| Manufacturer | A-S Medication Solutions |
|---|
| Substance Name | NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN |
|---|
| Strength | 10; 10; 10; 10 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|